Target intelligence / Profile preview

Perineural inflammatory and immune mediators

Molecular classification
Cytokine, Chemokine, Lipid mediator, Growth factor, Neuropeptide
01

Overview

Perineural inflammatory and immune mediators refer to a complex collection of signaling molecules—including cytokines like TNF-alpha and IL-1 beta, chemokines, and lipid mediators such as prostaglandins—that accumulate around peripheral nerves during injury or infection. These substances collectively form an inflammatory milieu that significantly influences the pharmacodynamics of local anesthetics. One primary mechanism of interference is the induction of local tissue acidosis; because local anesthetics are weak bases, a lower pH increases the ionized fraction of the drug, preventing it from crossing the neuronal lipid bilayer to reach its intracellular target on voltage-gated sodium channels. Additionally, these mediators can directly modulate the expression and gating properties of sodium channels, often leading to a state of hyperexcitability known as peripheral sensitization. This sensitization can result in clinical anesthetic resistance, where standard doses of drugs like lidocaine or bupivacaine fail to provide adequate analgesia. Understanding these interactions is critical for clinical anesthesiology, as the co-administration of anti-inflammatory adjuncts like dexamethasone is often employed to neutralize these mediators and prolong the efficacy of regional nerve blocks.

Other names
Inflammatory soupPerineural cytokinesPro-nociceptive mediatorsInflammatory milieu
02

Mechanism of action

Local anesthetics primarily inhibit voltage-gated sodium channels to block nerve conduction; however, perineural mediators modulate this effect by altering local pH (acidosis), which reduces anesthetic bioavailability, and by directly sensitizing sodium channels (e.g., Nav1.7, Nav1.8), which can lead to anesthetic resistance.

03

Biological functions

Immune responseInflammationNociceptionSignal transductionPeripheral sensitization
04

Disease associations

Neuropathic painInflammatory painPostoperative painComplex regional pain syndrome
05

Safety considerations

Anesthetic failureReduced duration of blockIncreased risk of neurotoxicity in inflamed tissueAltered systemic absorption rates
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Prostaglandin E2 (PGE2)C-reactive protein (CRP)

Beyond the preview

Go deeper on Perineural inflammatory and immune mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perineural inflammatory and immune mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call